Lv11
90 积分 2025-03-10 加入
Nintedanib in Patients With Autoimmune Disease–Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial
4天前
已完结
The Clinical Efficacy and Safety of Nintedanib in the Treatment of Interstitial Lung Disease Among Patients With Systemic Sclerosis: Systematic Review
4天前
已完结
P.083 Efficacy and safety of nintedanib in systemic sclerosis-associated interstitial lung disease: one-year results from the remscle cohort
4天前
求助中
Nintedanib Therapy Alone and Combined with Mycophenolate in Patients with Systemic Sclerosis–Associated Interstitial Lung Disease: Systematic Reviews and Meta-Analysis
4天前
已完结
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study
4天前
已完结
Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease
4天前
已完结
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
4天前
已完结
Association between SLCO1B1 polymorphism and methotrexate-induced hepatotoxicity: a systematic review and meta-analysis
5天前
已完结
Effect of TNF inhibitors on bone mineral density in rheumatoid arthritis patients receiving bisphosphonate: a retrospective cohort study
18天前
已完结
Skeletal muscle disease in rheumatoid arthritis: the center of cardiometabolic comorbidities?
18天前
已完结
皖公网安备34019202002308
